2Greenson JK, Isenhart CE. Identification of occult micrometastases in pericolic lymph nodes of Dukes'B colorectal cancerpatients using monoclonal antibodies against cytokeratin and CC49: correlation with long-term survival. Cancer, 2002, 73(3):563-569.
3Lindemann F, Schlimok G, Dirschedl P, et al. Prognostic significance of tumor cells in bone marrow of colorectal cancerpatients. Lancet, 1992,340 (8821) : 685-689.
4Cutait R, Aires VAF, Lopes LC, et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases staining of CEA and cytokeratins. Dis Colon Rectum,2001,34(10):917-920.
5O'Sullivan GC, Collins JK, Kelly J, et al. Micrometastases:marker of metastatic potential or evidence of residual disease?Gut, 1997,40(4) : 512-515.
6Funaki NO, Tanaka J, Itami A, et al. Detection of colorectal carcinoma cell in circulating peripheral blood by reverse transcription-polymerase chain reaction targeting cytokeratin-20 mRNA. Life Sci,1997,60(9) :643.
7Dems MG,Lipart C,LeBorgne J,et al. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer,1997,74(5):540.
8Burchill SA, Bradbury MF, Pittman K, et al. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer, 1995, 71 ( 2 ) :278.
9Mori M, Mimori K, Ueo H, et al. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Onco1,1998,16(1) :128.
10Wong LS, Cantrill JE ,Odogwu S,et al. Detection of circulating tumor cells and nodal metastasis by reverse transcriptase-polymerase chain reaction technique. Br J Surg, 2002,84 (6) :834.